Search

Author/Creator Falkenberg, Natalie

1. Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo. Issue 1 (6th September 2014)

Authors:
Falkenberg, Natalie; Anastasov, Nataša; Höfig, Ines; Bashkueva, Ksenia; Lindner, Katrin; Höfler, Heinz; Rosemann, Michael; Aubele, Michaela
Journal:
Molecular oncology
Issue:
Volume 9:Issue 1(2015:Jan.)
Page Start:
282
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer. (14th January 2016)

Authors:
Falkenberg, Natalie; Höfig, Ines; Rosemann, Michael; Szumielewski, Justine; Richter, Sabine; Schorpp, Kenji; Hadian, Kamyar; Aubele, Michaela; Atkinson, Michael J.; Anastasov, Nataša
Journal:
Cancer medicine
Issue:
Volume 5:Number 4(2016:Apr.)
Page Start:
703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. UPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R. Issue 1 (December 2016)

Authors:
Huber, Michaela; Mall, Rebecca; Braselmann, Herbert; Feuchtinger, Annette; Molatore, Sara; Lindner, Katrin; Walch, Axel; Gross, Eva; Schmitt, Manfred; Falkenberg, Natalie; Aubele, Michaela
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗